(Q33222417)

English

Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

object named as

Baohai Shao

1

0 references

5

object named as

Koji Uchida

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

author name string

Xiaoyun Fu

2

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Thomas O McDonald

3

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Pattie S Green

4

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Kevin D O'Brien

6

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

John F Oram

7

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Jay W Heinecke

8

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

language of work or name

0 references

publication date

25 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

280

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

36386-36396

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Protein oxidation and aging

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Biological interactions of alpha,beta-unsaturated aldehydes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Protein-bound acrolein: potential markers for oxidative stress

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsatu

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Current status of acrolein as a lipid peroxidation product

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Role of oxidized low density lipoprotein in atherogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

N(epsilon)-(3-methylpyridinium)lysine, a major antigenic adduct generated in acrolein-modified protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Immunochemical crossreactivity of antibodies specific for "advanced glycation endproducts" with "advanced lipoxidation endproducts".

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

High-density lipoprotein--the clinical implications of recent studies

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Tangier disease as a test of the reverse cholesterol transport hypothesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

New insights into the regulation of HDL metabolism and reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Inhibition of Lecithin-Cholesterol Acyltransferase and Modification of HDL Apolipoproteins by Aldehydes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol Efflux

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Acrolein modifies apolipoprotein A-I in the human artery wall

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Cell proliferation in human coronary arteries

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

The effects of altered apolipoprotein A-I structure on plasma HDL concentration

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Apolipoprotein structural organization in high density lipoproteins: belts, bundles, hinges and hairpins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via the ATP-binding cassette transporter ABCA1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Identification of an apolipoprotein A-I structural element that mediates cellular cholesterol efflux and stabilizes ATP binding cassette transporter A1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Presence of hypochlorite-modified proteins in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Structural models of human apolipoprotein A-I.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508169200

21 January 2018

Identifiers

10.1074/JBC.M508169200

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33222417&oldid=1837297437"